Kyntra Bio KYNB 深 沪
交易中 09-16 11:00:46 美东时间
7.78
+0.010
+0.13%
华盛通- 最 高7.78
- 今 开7.78
- 成交量 373股
- 最 低 7.78
- 昨 收 7.77
- 总市值 3150.22万
- 52周最高 12.58
- 市盈率 静 0.17
- 换手率 0.01%
- 52周最低 6.32
- 委 比 93.22%
- 总股本 404.91万
- 历史最高 1713.75
- 量 比 0.07
- 振 幅 0.00%
- 历史最低 4.50
- 每 手 1
- 风险率 1.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
HC Wainwright & Co. Reiterates Buy on Kyntra Bio, Maintains $43 Price Target
HC Wainwright & Co. analyst Matthew Keller reiterates Kyntra Bio (NASDAQ:KYNB) with a Buy and maintains $43 price target.
09-01 18:26
Kyntra Bio Streamlines Financing, Strengthens Balance Sheet
Kyntra Bio ( ($KYNB) ) has shared an update. On August 31, 2026, Kyntra Bio ame...
09-01 05:52
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Kyntra Bio amended its royalty financing agreement with NQ Project Phoebus, L.P., reducing maximum payments from $125 million to $65 million. The company made a $42.6 million accelerated upfront payment, returning NQ's invested capital, with up to $15 million in additional payments. Remaining payments are capped at $15 million, sourced from 50% of revenue from Astellas territories excluding Japan. The amendment strengthens Kyntra's financial posi...
08-31 20:05
UPDATE: Kyntra Bio Q2 Adj. EPS $(4.68) Misses $(3.18) Estimate, Sales $(1.474M) Miss $2.007M Estimate
Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(4.68) per share which missed the analyst consensus estimate of $(3.18) by 47.17 percent. This is a 148.94 percent decrease over losses of $(1.88) per share from the same period last year. The company reported quarterly sales of $(1.474 million)...
08-14 06:07
Kyntra Bio Q2 2026 Earnings Call: Complete Transcript
On Thursday, Kyntra Bio (NASDAQ:KYNB) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. Access the ful...
08-14 05:59
美股大行评级 | 最高800美元！16家大行首予SpaceX"买入"或"超配"评级；奥本海上调康宁目标价从210美元升至230美元
今日重点评级关注：Canaccord Genuity：维持AtaiBeckley"买入"评级，目标价从15美元升至17美元；Truist Securities：维持NUVATION BIO"买入"评级，目标价从12美元升至13美元
07-08 15:31
Oppenheimer Initiates Coverage On Kyntra Bio with Outperform Rating, Announces Price Target of $35
Oppenheimer analyst Jay Olson initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Outperform rating and announces Price Target of $35.
07-07 17:31
美股大行评级 | 潜在涨幅321.55%！Shattuck Labs获花旗升目标价至18美元，维持"买入"评级
今日重点评级关注：花旗：维持Shattuck Labs"买入"评级，目标价从7美元升至18美元；Benchmark：维持Gloo Holdings"买入"评级，目标价从14美元升至15美元
06-10 12:32
Rodman & Renshaw Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $30
Rodman & Renshaw analyst Michael G. King Jr. initiates coverage on Kyntra Bio (NASDAQ:KYNB) with a Buy rating and announces Price Target of $30.
06-09 19:50
